0
0

Improving Medical Device Innovation Act

1/11/2023, 1:31 PM

Congressional Summary of S 2737

Improving Medical Device Innovation Act

This bill amends the Federal Food, Drug, and Cosmetic Act to revise provisions related to medical device performance standards, reporting requirements, and classification panels.

A person may request that the Food and Drug Administration (FDA) recognize a performance standard established by a recognized standards organization as a standard to which a medical device may conform in order to meet an FDA requirement. When a request to recognize a standard is received, the FDA must determine whether to recognize all, part, or none of the standard and publish the rationale for that determination. (Currently, the FDA recognizes certain performance standards, but it is not required to respond to requests or publish rationales.)

The FDA must:

  • train employees who review premarket submissions for medical devices on recognized standards;
  • review its published principles for recognizing standards;
  • identify types of medical devices for which a premarket report is no longer needed to provide reasonable assurance of safety and effectiveness;
  • ensure that adequate expertise is represented on medical device classification panels;
  • provide an opportunity for a person whose premarket submission is subject to review by a classification panel to recommend expertise needed on the panel; and
  • provide opportunities for patients, patient representatives, and medical device sponsors to recommend individuals for positions on classification panels.
The FDA, in coordination with medical device manufacturers, must establish pilot projects to evaluate alternative methods of compliance with reporting requirements for certain medical devices. The Government Accountability Office must report on these pilot projects.

Current Status of Bill S 2737

Bill S 2737 is currently in the status of Bill Introduced since March 17, 2016. Bill S 2737 was introduced during Congress 114 and was introduced to the Senate on March 17, 2016.  Bill S 2737's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of March 17, 2016

Bipartisan Support of Bill S 2737

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
1
Democrat Cosponsors
0
Republican Cosponsors
1
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 2737

Primary Policy Focus

Health

Potential Impact Areas

- Administrative law and regulatory procedures
- Congressional oversight
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Food and Drug Administration (FDA)
- Government studies and investigations
- Health technology, devices, supplies
- Technology assessment

Alternate Title(s) of Bill S 2737

Improving Medical Device Innovation Act
A bill to improve medical device innovation.
Improving Medical Device Innovation Act

Comments